PvVespk

General Information


DCTPep ID  DCTPep01173

Peptide Name   PvVespk

Sequence  GRPPGFSPFRSG

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Not available

Type  Synthetic peptide

Classification

  

ACP



Activity Information


Hemolytic Activity  Human red blood cell: show very low hemolytic activity

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C57H84N18O15

Absent amino acids  ACDEHIKLMNQTVWY

Theoretical pI  12.00

Acidic residues  0

Basic residues  2

Polar residues  5

Molecular weight (Average)  1261.41

Molecular weight (Monoisotopic)  1260.64

Common amino acids  GP

Net charge  2

Instability index (II)  130.55

Aliphatic index  0.00

Grand average of hydropathicity (GRAVY)  -0.917

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID KR101990437B1

Patent Title  Peptide from Parapolybia varia having antitumor activity and uses thereof

Other Iinformation  Granted Patent; Family: 2s / 2ex; Family Jurisdictions: KR; Legal Status: Active; Application No: 20170037330; Filed: Mar 24, 2017; Published: Jun 19, 2019; Earliest Priority: Mar 24, 2017; Granted: Jun 19, 2019

Other Published ID  KR101990437B1   




DCTPep is developed by Dr.Zheng's team.